Blog

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place their device on the UK market. Learn what this means for your organization and how to prepare.

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…

Patient reported outcome measures in clinical trials have traditionally been done on paper. Surveys are a common way…

User Acceptance Testing (UAT) is a critical component in the clinical trial process. Its primary goal is to…

Most researchers around the world use tools like Microsoft Excel, Microsoft Access, Google Forms, or SPSS for data…

Randomization is a key feature of clinical trials aiming for a valuable study outcome. In this article we will explain the concept, its purpose and how it can be applied in practice.

The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here…